ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
Hypertriglyceridemia results from accumulation of triglyceride (TG)-rich lipoproteins (TRLs) in the circulation and is associated with increased CVD risk. ApoC-III is an apolipoprotein on TRLs and a prominent negative regulator of TG catabolism. We recently established that in vivo apoC-III predomin...
Main Authors: | Bastian Ramms, Sohan Patel, Chelsea Nora, Ariane R. Pessentheiner, Max W. Chang, Courtney R. Green, Gregory J. Golden, Patrick Secrest, Ronald M. Krauss, Christian M. Metallo, Christopher Benner, Veronica J. Alexander, Joseph L. Witztum, Sotirios Tsimikas, Jeffrey D. Esko, Philip L.S.M. Gordts |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-08-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520322331 |
Similar Items
-
Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins
by: Jeremy D. Furtado, et al.
Published: (2012-04-01) -
Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL
by: Marit Westerterp, et al.
Published: (2006-06-01) -
New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia
by: Martine Groenendijk, et al.
Published: (2001-02-01) -
Synthesis and secretion of apoC-I and apoE by human SW872 liposarcoma cells
by: Wassef, Hanny
Published: (2004) -
Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL
by: Jimmy F.P. Berbée, et al.
Published: (2005-02-01)